Skip to main content
Active Clinical Trials

Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy

By April 24, 2017No Comments

Condition

Pleural Mesothelioma|Peritoneal Mesothelioma

Estimated Enrollment: 20

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: 100146|10-C-0146

Study First Received: July 9, 2010

Last Updated: August 31, 2016

Estimated Primary Completion Date: April 2012

 

Primary Outcome Measures:

Clinical Response Rate (PR+CR)|Safety of IMC-A12 in Patients With Mesothelioma

Sponsors and Collaborators:

National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)

Website Link: https://ClinicalTrials.gov/show/NCT01160458

Leave a Reply